The Awards recognise thought leadership on a global scale, unveiling top pharmaceutical innovators to global trade. They honour companies that are driving forward industry changing initiatives across innovation within three broad categories — ‘Formulation’, ‘Process Development’ and ‘Packaging’— with just one winner to each prestigious award. The CPhI Worldwide 2013 exhibition takes place on 22–24 October, at the Messe Frankfurt in Germany, and winners of the CPhI Pharma Awards will be announced at a ceremony during the evening of 22 October.
CPhI is now accepting applications for the 2013 CPhI Pharma Awards, open to individuals and companies responsible for developing pharmaceutical innovations over the past year.
“The CPhI Pharma Awards are the ideal opportunity to present exciting, breakthrough innovations to the pharmaceutical industry. We are proud to be entering our 10th year of running the awards to acknowledge and recognise the sheer determination and efforts that companies pour into their work,” Andrew Pert, Pharma Brand Director, noted. “This year we have three categories and there will be one winner for each ‘Best Innovation in Formulation’, ‘Best Innovation in Process Development’ and ‘Best Innovation in Packaging’. Not only do companies receive the recognition that they deserve for their outstanding innovations, but entry into the Pharma Awards also gives unrivalled exposure to the media, whilst raising company profiles amongst key pharmaceutical industry professionals and VIPs.”
Last year at the Feria de Madrid in Spain, Haemopharm Healthcare was awarded gold in the Best Innovation category for its needle-free vial closure, designed to connect a syringe and vial without any further components; the needle-free system facilitated an easier administration of parenteral drugs. Merck Millipore took silver for its drug delivery platform using silica, which takes full advantage of the large surface area and good transport properties that silica possesses. The bronze award was won by Bio Clin BV for its Multi-Oral Remin remineralisation gel for application in the oral cavity, a self-care product especially suitable for people that regularly take medication.
Haemopharm Healthcare’s Marketing Communications Manager Dana Barocas expressed the benefits that the CPhI Pharma Awards has brought the company: “Our winning at the CPhI Pharma Awards has enhanced our presence not only at the show but also to all of our contacts, whilst giving us a great exposure and visibility within the pharmaceutical trade media — magazines and websites — as well as in the medical devices field, bringing interesting and fruitful business and cooperation opportunities.”
Entries are now open to both exhibitors and visitors of CPhI Worldwide, as well as the wider pharma community, through to 26 July. After the deadline, the jury panel will meet to select the finalists for each category; the panel includes senior figures from companies including CU Chemie Uetikon, Merck & Cie and PharmAccel Consulting. Finalists will present their innovations during the morning of the first show day to the jury, press and visitors. The winners will then be formally announced during the awards ceremony and reception taking place the same evening in the Messe Frankfurt Europa Room.
To learn more about the awards, or to submit an award entry, please visit www.cphi.com/pharma-awards.
For more information about CPhI Worldwide, ICSE, InnoPack, BioPh and P-MEC Europe, please visit www.cphi.com.